Skip to Main Content

Madeline Mayday

DownloadHi-Res Photo

About

Biography

Madeline Mayday is a PhD Candidate in the Department of Pathology and is a Medical Research Scholar. Originally from Muskoka, Ontario, she graduated with a B.S. in Cell and Molecular Biology from San Francisco State University. Following her undergraduate career she worked as a Research Associate at UCSF to develop a protocol for detection of pathogens causing respiratory failure in pediatric HSC transplant patients. Madeline started her graduate studies in Yale’s MMPP program in Fall 2019 and joined the Krause Lab in May 2020 with an interest in translational research and malignant hematopoiesis. She is currently working on a project to better understand the development of AMKL, a rare neonatal leukemia.

Madeline is a Chief Graduate Student for the Department of Pathology.

Education & Training

Medical Research Scholars Program
Yale Univeristy (2023)
MPhil
Yale University (2021)
BS
San Francisco State University (2017)

Research

Research at a Glance

Yale Co-Authors

Frequent collaborators of Madeline Mayday's published research.

Publications

2024

  • Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.
    Zinter MS, Dvorak CC, Mayday MY, Reyes G, Simon MR, Pearce EM, Kim H, Shaw PJ, Rowan CM, Auletta JJ, Martin PL, Godder K, Duncan CN, Lalefar NR, Kreml EM, Hume JR, Abdel-Azim H, Hurley C, Cuvelier GDE, Keating AK, Qayed M, Killinger JS, Fitzgerald JC, Hanna R, Mahadeo KM, Quigg TC, Satwani P, Castillo P, Gertz SJ, Moore TB, Hanisch B, Abdel-Mageed A, Phelan R, Davis DB, Hudspeth MP, Yanik GA, Pulsipher MA, Sulaiman I, Segal LN, Versluys BA, Lindemans CA, Boelens JJ, DeRisi JL, Pediatric Transplantation and Cell Therapy Consortium. Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation. Nat Med 2024 PMID: 38783139, DOI: 10.1038/s41591-024-02999-4.
    Peer-Reviewed Original Research

2023

  • Pulmonary microbiome and transcriptome signatures reveal distinct pathobiologic states associated with mortality in two cohorts of pediatric stem cell transplant patients.
    Zinter MS, Dvorak CC, Mayday MY, Reyes G, Simon MR, Pearce EM, Kim H, Shaw PJ, Rowan CM, Auletta JJ, Martin PL, Godder K, Duncan CN, Lalefar NR, Kreml EM, Hume JR, Abdel-Azim H, Hurley C, Cuvelier GDE, Keating AK, Qayed M, Killinger JS, Fitzgerald JC, Hanna R, Mahadeo KM, Quigg TC, Satwani P, Castillo P, Gertz SJ, Moore TB, Hanisch B, Abdel-Mageed A, Phelan R, Davis DB, Hudspeth MP, Yanik GA, Pulsipher MA, Sulaiman I, Segal LN, Versluys BA, Lindemans CA, Boelens JJ, DeRisi JL, Pediatric Transplantation and Cell Therapy Consortium. Pulmonary microbiome and transcriptome signatures reveal distinct pathobiologic states associated with mortality in two cohorts of pediatric stem cell transplant patients. MedRxiv 2023 PMID: 38077035, DOI: 10.1101/2023.11.29.23299130.
    Peer-Reviewed Original Research

2022

2021

2020

2019

Academic Achievements & Community Involvement

  • honor

    Ruth L. Kirschstein Predoctoral Individual National Research Service Award (F31)

  • honor

    Lo Graduate Fellowship for Excellence in Stem Cell Research

  • honor

    Pilot & Feasibility Award (Type B)